MDT stock price:$107.830.04%At close on August 22nd, 2019
Updated on: August 22nd, 2019
5
After marking all time highs on Tuesday, Medtronic remained constant 0.04% yesterday to $107.83. Thursday was the 5th climbing day in a row, marking 6.02%.
Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide.
Should I buy Medtronic stock?
You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing.Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them.There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, 2 buy setups match with Medtronic stock now:
Buy setup
Elegible
New all-time high
Yes
New 52 week high
Yes
Price crossing up 200d MA
No
100d MA crossing up 200d MA
No
Is Medtronic stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.
At Stocks2.com, we detected 15 ratings published for MDT stock in the last 30 days.The general sentiment of these ratings is bullish for MDT stock, with 11 positive ratings.
Is MDT a good stock to buy?
Date
Analyst / Broker
Previous rating
Current rating
2019-8-21
Wells Fargo & Co
n/a
Outperform
2019-8-21
UBS Group
n/a
Buy
2019-8-21
Stifel Nicolaus
n/a
Hold
2019-8-21
Raymond James
n/a
Buy
2019-8-21
Raymond James
n/a
Outperform
2019-8-21
Northland Securities
n/a
Hold
2019-8-21
Morgan Stanley
n/a
Equal Weight
2019-8-21
BTIG Research
n/a
Buy
2019-8-21
BMO Capital Markets
n/a
Outperform
2019-8-21
BMO Capital Markets
n/a
Outperform
2019-8-21
Barclays
n/a
Overweight
2019-8-19
Deutsche Bank
n/a
Buy
2019-8-16
Royal Bank of Canada
n/a
Outperform
2019-8-14
Morgan Stanley
n/a
Equal Weight
2019-8-14
Cowen
n/a
Outperform
Medtronic stock analysis
Daily outlook
After marking all time highs on Tuesday, Medtronic remained constant 0.04% to $107.83.
After topping to all time highs on Tuesday, Medtronic remained steady 0.04% to $107.83. On July, SMA100d and SMA200d crossed up triggering a rise of 11.33%. Since price and SMA200d lines crossed up on May, MDT climbed $19.56 (22.16%). From a daily perspective, MDT is in a short term uptrend after plotting its last bottom ($100.63, on Aug/15) higher than the previous bottom, and its last top ($109.70, on Tuesday) also over the previous top. Now trading in between its last bottom and last top MDT might consolidate in a plain range, waiting to break out over $109.70 or down under $100.63. On Tuesday, MDT hit a new all time high, pushing higher than on Monday tops. Check different trading setups that use ATHs as triggers.
MDT stock chart (daily)
Weekly outlook
Medtronic ended this week at $107.83 after reaching a new all time high ($109.70) and climbed a cool 4.93%.
MDT shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom early August, MDT climbed unceasignly breaking out to new all time highs. Since SMA20d and SMA40w crossed up late June, MDT price climbed $8.99 per share (9.10%). Since price and SMA40w lines crossed up late May, MDT climbed $20.58 (23.59%).
MDT stock chart (weekly)
Medtronic stock price history
Medtronic stock historical price chart
MDT stock reached all-time highs on Tuesday with a price of $109.70.
Medtronic stock price target is $114.10
Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We have 15 price predictions for MDT stock published in the last 30 days:
MDT stock price predictions
Date
Analyst / Broker
Action
Previous target
Current target
Diff
2019-8-21
Wells Fargo & Co
Reiterates
$110.00
$120.00
9.1%
2019-8-21
UBS Group
Raises Target
$112.00
$122.00
8.9%
2019-8-21
Stifel Nicolaus
Reiterates
$95.00
$112.00
17.9%
2019-8-21
Raymond James
Reiterates
$105.00
$118.00
12.4%
2019-8-21
Raymond James
Raises Target
$105.00
$118.00
12.4%
2019-8-21
Northland Securities
Reiterates
n/a
$100.00
-
2019-8-21
Morgan Stanley
Raises Target
$105.00
$111.00
5.7%
2019-8-21
BTIG Research
Raises Target
n/a
$120.00
-
2019-8-21
BMO Capital Markets
Reiterates
$107.00
$118.00
10.3%
2019-8-21
BMO Capital Markets
Raises Target
$107.00
$118.00
10.3%
2019-8-21
Barclays
Raises Target
$110.00
$117.00
6.4%
2019-8-19
Deutsche Bank
Reiterates
$100.00
$111.00
11%
2019-8-16
Royal Bank of Canada
Raises Target
n/a
$110.00
-
2019-8-14
Morgan Stanley
Raises Target
$100.00
$105.00
5%
2019-8-14
Cowen
Reiterates
$99.00
$111.00
12.1%
(in average)
$104.60
$114.10
9.0%
The price prediction for Medtronic stock is $114.10, moving in a range between $122.00 and $100.00. In average, analysts' outlook on MDT price target is positive, improving the target by a 9.00% from previous estimations.
Financials and fundamental analysis
Earnings date and Earnings per Share
Medtronic presented slightly good results for 2019-Q1 on February. Medtronic appreciated Earnings per Share (EPS) by 4.00%, beating analysts consensus of $1.24. Medtronic posted $1.29.
MDT earnings date and EPS evolution
Quarter
Reporting date
Estimated EPS
Actual EPS
Surprise
2017-Q2
-
n/a
n/a
n/a
2017-Q3
-
n/a
n/a
n/a
2017-Q4
-
n/a
n/a
n/a
2018-Q1
2018-02-20
1.16
1.17
0.9%
2018-Q2
2018-05-24
1.38
1.42
2.9%
2018-Q3
2018-08-21
1.11
1.17
5.4%
2018-Q4
2018-11-20
1.14
1.22
7.0%
2019-Q1
2019-02-19
1.24
1.29
4.0%
2019-Q2
-
n/a
n/a
n/a
2019-Q3
-
n/a
n/a
n/a
Annual financial results
In 2018, Medtronic annual sales remained steady a tight 0.01% to $29,953.00 million USD from $29,950.00 marked in 2018.When comparing 2018 vs 2018, aligned with this, profit margin (that is, the net income divided by revenues) stayed stable a 0.01% to 10.36%.To have an updated view of the financial situation of Medtronic, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Medtronic TTM sales up to January 2019 were $30,555.00 and earnings were $4,919.00 M USD.If we compare this TTM figures with the last reported annuality, we can review Medtronic business evolution since April 2018: Annual sales up to January, compared to lastest yearly report, grew a slightly good 2.01%.Regarding profit margin, Medtronic soared 5.74% to 10.36%
MDT annual Sales and Income evolution
Year
Sales
YoY
Income/(margin)
YoY
2014
$17,010 M
-
$3,070 M18.0%
-
2014
$17,010 M
0.00%
$3,070 M18.0%
0.00%
2015
$20,260 M
19.11%
$2,680 M13.2%
-12.70%
2015
$20,261 M
0.00%
$2,675 M13.2%
-0.19%
2016
$28,830 M
42.29%
$3,540 M12.3%
32.34%
2016
$28,833 M
0.01%
$3,538 M12.3%
-0.06%
2017
$29,710 M
3.04%
$4,030 M13.6%
13.91%
2017
$29,710 M
0.00%
$4,028 M13.6%
-0.05%
2018
$29,950 M
0.81%
$3,100 M10.4%
-23.04%
2018
$29,953 M
0.01%
$3,104 M10.4%
0.13%
TTM
$30,555 M
2.01%
$4,919 M16.1%
58.47%
Quarterly financial results
Medtronic reported $7,546.00 million in revenues for 2019-Q1, a 0.87% improvement compared to previous quarter.Reported quarter earnings marked $1,269.00 million with a profit margin of 16.82%. Profit margin inched a 1.91% compared to previous quarter when profit margin was 14.90%.When comparing revenues to same quarter last year, Medtronic sales marked a tiny growth and stepped up a 2.40%.Looking back to recent quarterly results, Medtronic posted 2 positive quarters in a row.
MDT quarterly Sales and Income evolution
Quarter
Sales1
QoQ2
Income1/(margin)
QoQ2
2017-Q2
$7,920 M
-
$1,160 M14.6%
-
2017-Q3
$7,390 M
-6.69%
$1,020 M13.8%
-12.07%
2017-Q4
$7,050 M
-4.60%
$2,017 M28.6%
97.75%
2018-Q1
$7,369 M
4.52%
$-1,389 M-18.8%
-168.86%
2018-Q2
$8,144 M
10.52%
$1,460 M17.9%
-205.11%
2018-Q3
$7,384 M
-9.33%
$1,075 M14.6%
-26.37%
2018-Q4
$7,481 M
1.31%
$1,115 M14.9%
3.72%
2019-Q1
$7,546 M
0.87%
$1,269 M16.8%
13.81%
Medtronic ownership
When you are planning to invest in a stock, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medtronic, 0.06% of all outstanding shares are owned by its staff.
Bearish positions for MDT stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
MDT
ABT
BAX
BSX
CNMD
Market cap
$0.0 M
$148.5 B
$44.5 B
$59.3 B
$2.9 B
Total shares
0.0 M
1,760.0 M
510.2 M
1,390.0 M
28.3 M
Float shares
1,340.0 M
1,750.0 M
509.5 M
1,390.0 M
27.6 M
- Institutional holdings (%)
84.2%
76.5%
88.2%
93.4%
97.5%
- Insider holdings (%)
0.1%
0.7%
0.1%
0.2%
1.8%
Shares in short selling
0.0%
0.0%
0.0%
0.0%
0.0%
Medtronic summary
Thursday, August 22nd, 2019
Open
$108.00
Close
$107.83
Day range
$107.23 - $108.31
Previous close
$107.79
Session gain
0.04%
Average true range
$2.07
50d mov avg
$100.51
100d mov avg
$94.84
200d mov avg
$92.27
Daily pattern
lt06a
Weekly pattern
lb03c
Medtronic performance
To measure stock performance is always good to benchmark with competitors or related stocks. We chose , Baxter International, Boston Scientific, CONMED, Edwards Lifesciences, Integra LifeSciences, , Owens & Minor, Stryker and Zimmer Biomet as the bechmarking frame for Medtronic stock.
Stock
3m
6m
12m
MDTMedtronic
16.55%
16.26%
15.33%
ABT
10.01%
11.69%
29.78%
BAXBaxter Internatio...
16.45%
17.41%
21.84%
BSXBoston Scientific
10.92%
5.31%
22.90%
CNMDCONMED
24.26%
33.89%
31.07%
EWEdwards Lifescien...
27.92%
25.60%
52.88%
IARTIntegra LifeScien...
25.65%
12.10%
3.88%
JNJ
-5.46%
-2.60%
-0.86%
OMIOwens & Minor
38.51%
-24.33%
-70.27%
SYKStryker
18.84%
16.69%
30.31%
ZBHZimmer Biomet
19.98%
10.63%
10.23%
Medtronic competitors
We selected a few stocks to conform a list of Medtronic competitors to check if you are interested in investing in MDT: